Elliot L. Chaikof, Ph.D., M.D.
This page shows the publications co-authored by Elliot Chaikof and Jiaxuan Chen.
Modulation of lymphocyte-mediated tissue repair by rational design of heterocyclic aryl hydrocarbon receptor agonists. Sci Adv. 2020 01; 6(3):eaay8230.
Immune checkpoint regulator: a new assignment proposed for the classic adhesion molecule P-selectin glycoprotein ligand-1. Transl Cancer Res. 2016 Oct; 5(Suppl 4):S668-S671.
An immobilized liquid interface prevents device associated bacterial infection in vivo. Biomaterials. 2017 01; 113:80-92.
A PSGL-1 glycomimetic reduces thrombus burden without affecting hemostasis. Blood. 2021 09 30; 138(13):1182-1193.
Resident and elicited murine macrophages differ in expression of their glycomes and glycan-binding proteins. Cell Chem Biol. 2021 04 15; 28(4):567-582.e4.
Targeting P-selectin glycoprotein ligand-1/P-selectin interactions as a novel therapy for metabolic syndrome. Transl Res. 2017 05; 183:1-13.
Efferocytosis as a regulator of macrophage chemokine receptor expression and polarization. Eur J Immunol. 2016 07; 46(7):1592-9.
Syndecan-1 modulates the motility and resolution responses of macrophages. Arterioscler Thromb Vasc Biol. 2015 Feb; 35(2):332-40.
Sulfated poly-amido-saccharides (sulPASs) are anticoagulants in vitro and in vivo. Chem Sci. 2021 Oct 06; 12(38):12719-12725.
The connection strength for co-authors is the sum of the scores for each of their shared publications.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.